Immunization with human immunodeficiency virus type 1 rgp120(W61D) in QS21/MPL adjuvant primes T cell proliferation and C-C chemokine production to multiple epitopes within variable and conserved domains of gp120(W61D)

Journal of Infectious Diseases

Volumn 179, Issue 3, 1999, Pages 558-566

  Jones, Gareth J ^a,b   Von Hoegen, Paul ^a,b   Weber, Jonathan ^a,b   Rees, Ann D ^a,b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b SmithKline Beecham Biologicals   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BETA CHEMOKINE; EPITOPE; GLYCOPROTEIN GP 120; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES; VIRUS GLYCOPROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CELL LINE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNIZATION; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; T LYMPHOCYTE;

AIDS VACCINES; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CHEMOKINES, CC; CONSERVED SEQUENCE; EPITOPES; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT PROTEINS; T-LYMPHOCYTES; VACCINES, SYNTHETIC;

EID: 0033396632     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314626     Document Type: Article

References (54)

1. 1. Li CR, Greenberg PD, Gilbert MJ, Goodrich JM, Riddell SR. Recovery of cytomegalovirus (CMV)-specific T-cell response after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis. Blood 1994;83:1971-9.
2. 2. Siliciano RF, Bollinger RC, Callahan KM, et al. Clonal analysis of T-cell responses to the HIV-1 envelope proteins in AIDS vaccine recipients. AIDS Res Hum Retroviruses 1992;8:1349-52.
3. 3. Sissons JG, Oldstone MB. Antibody-mediated destruction of virus-infected cells. Adv Immunol 1980;29:209-60.
4. 4. Sissons JG, Oldstone MB. Killing of virus-infected cells by cytotoxic lymphocytes. J Infect Dis 1980;142:114-80.
5. 5. Koszinowski UH, Reddchase MJ, Jonjic S. The role of CD4 and CD8 T cells in viral infection. Curr Opin Immunol 1991;3:471-5.
6. 6. Doherty PC, Allan W, Eichelberger M, Carding SR. Roles of alpha beta and gamma delta T cell subsets in viral immunity. Annu Rev Immunol 1992;10: 123-51.
7. 7. Ahearne PM, Mathews TJ, Lyerly HK, White GC, Bolognesi DP, Weinhold KJ. Cellular immune response to viral peptides in patients exposed to HIV. AIDS Res Hum Retroviruses 1988;4:259-67.
8. 8. Walker CM, Steimer KS, Rosenthal KL, Levy JA. Identification of human immunodeficiency virus (HIV) envelope type-specific T helper cells in an HIV-infected individual. J Clin Invest 1988;82:2172-5.
9. 9. Clerici M, Stocks NI, Zajac RA, et al. Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals. Nature 1989;339:383-5.
10. 10. Mathiesen T, Broliden PA, Rosen J, Wahren B. Mapping of IgG subclass and T-cell epitopes on HIV proteins by synthetic peptides. Immunology 1989;67:453-9.
11. 11. Schrier RD, Gnan JW Jr, Landes R, et al. T cell recognition of HIV synthetic peptides in natural infection. J Immunol 1989;142:1166-76.
12. 12. Wahren B, Rosen J, Sandstrom E, Mathiesen T, Modrow S, Wigzell H. HIV-1 peptides induce a proliferative response in lymphocytes from infected persons. J Acquir Immune Defic Syndr 1989;2:448-56.
13. 13. Krowka J, Stites D, Debs R, et al. Lymphocyte proliferation responses to soluble and liposome-conjugated envelope peptides of HIV-1. J Immunol 1990;144:2535-40.
14. 14. Bell SJD, Cooper DA, Kemp BE, Doherty RR, Penny R. Definition of an immunodominant T-cell epitope contained in the envelope gp41 sequence of HIV-1. Clin Exp Immunol 1992;87:37-45.
15. 15. Mutch D, Underwood J, Geysen M, Rodda S. Comprehensive T-cell epitope mapping of HIV-1 env antigens reveals many areas recognised by HIV-1 -seropositive and by low-risk HIV-1-seronegative individuals. J Acquir Immune Defic Syndr 1994;7:879-90.
16. 16. Clerici M, Giorgi JV, Chou CC, et al. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J Infect Dis 1992; 165:1012-9.
17. 17. Tacket CO, Baqar S, Munoz C, Murphy JR. Lymphoproliferative responses to mitogens and HIV-1 envelope glycoprotein among volunteers vaccinated with recombinant gp160. AIDS Res Hum Retroviruses 1990;6: 535-42.
18. 18. Clerici M, Tacket TO, Via CS, et al. Immunization with subunit human immunodeficiency virus vaccine generates stronger T helper cell immunity than natural infection. Eur J Immunol 1991;21:1345-9.
19. 19. Cooney EL, McElrath MJ, Corey L, et al. Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp120 protein. Proc Natl Acad Sci USA 1993;90:1882-6.
20. + cytotoxic activity after receipt of envelope vaccines. J Infect Dis 1993;168:306-13.
21. 21. Gorse GJ, Schwartz DH, Graham BS, et al. HIV-1 recombinant gp160 vaccine given in accelerated dose schedules. Clin Exp Immunol 1994;98: 178-84.
22. + T-lymphocyte lines from HIV-1-seropositive patients. J Infect Dis 1995;171: 1420-30.
23. 23. Manca F, Habeshaw J, Dalgleish A. The naive repertoire of human T helper cells specific for gp120, the envelope glycoprotein of HIV. J Immunol 1991;146:1964-71.
24. 24. Fernandez MH, Faith A, Higgins JA, Weber J, Rees AD. The effect of a single amino acid substitution within the V3 loop of HIV-1 gp120 on HLA-DRI restricted CD4 T-cell recognition. Immunology 1995;85: 176-83.
25. + T-cell recognition of diverse clade B HIV-1 isolates. AIDS 1997;11:281-8.
26. + T cells. Science 1995;270:1811-5.
27. + T cells. Immunol Today 1996;17:217-24.
28. + cells is mediated by the chemokine receptor CC-CKR5. Nature 1996;381:667-73.
29. +' T-cells from exposed uninfected individuals expressing the wild-type CCR-5 allele. J Exp Med 1997;186:455-60.
30. 30. Weber J. MRC V-001 study: a comparative trial of RGP120 with novel adjuvants. In: Girard M, Dodet B, eds. Onzieme Colloque Des Cent Gardes: Retroviruses of Human AIDS and Related Animal Diseases, 27-29 October 1997, Paris.
31. 31. Botarelli P, Houlden BA, Haigwood NL, Servis C, Montagna D, Abrignani S. N-glycosylation of HIV-gp120 may constrain recognition by T-lymphocytes. J Immunol 1991;147:3128-32.
32. 32. Berzofsky JA, Bensussan A, Cease KB, et al. Antigenic peptides recognised by T lymphocytes from AIDS viral envelope immune humans. Nature 1988;334:706-8.
33. 33. Manca F, Habeshaw J, Dalgleish A, Fenoglio D, Li Pira G, Sercarz EE. Role of flanking variable sequences in antigenicily of consensus regions of HIV gp120 for recognition by specific human T helper clones. Eur J Immunol 1993;23:269-74.
34. 34. Nanda NK, Arzoo KK, Geysen HM, Sette A, Sercarz, EE. Recognition of multiple peptide cores by a single T cell receptor. J Exp Med 1995;182: 531-9.
35. 35. Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995;80:695-705.
36. 36. Gautam AM, Lock CB, Smilek DE, Pearson CL, Steinman L, McDevitt HO. Minimum structural requirements for peptide presentation by major histocompatibility complex class II molecules: implications in induction of immunity. Proc Natl Acad Sci USA 1994;91:767-71.
37. 37. Zugel U, Schoel B, Yamamoto S, Hengel H, Morein B, Kaufman SHE. Crossrecognition by CD8 T cell receptor αβ cytotoxic T lymphocytes of peptides in the self and mycobacterial hsp60 which share intermediate sequence homology. Eur J Immunol 1995;25:451-8.
38. 38. Evavold BD, Stoan-Lancaster J, Wilson KJ, Rothbard JB, Allen PM. Intramolecular mimicry. Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. Immunity 1995;2: 655-63.
39. 39. Hagerty DT, Allen PM. Intramolecular mimicry. Identification and analysis of two cross-reactive T cell epitopes within a single protein. J Immunol 1995;155:2993-3001.
40. 40. Schrum S, Probst P, Fleischer B, Zipfel PF. Synthesis of the C-C chemokines MIP-1α, MIP-1β, and RANTES is associated with a type 1 immune response. J Immunol 1996;157:3598-604.
41. + individuals: correlates with a Th1-type cytokine response. Clin Exp Immunol 1998;112:92-9.
42. 42. Callahan KM, Fort MM, Obah EA, Reinherz EL, Siliciano RF. Genetic variability in HIV-1 gp120 affects interactions with HLA molecules and T cell receptor. J Immunol 1990;144:3341-6.
43. 43. Brown LR, Nygard NR, Graham MB, et al. Recognition of the influenza hemagglutinin by class II MHC-restricted T lymphocytes and antibodies. I. Site definition and implications for antigen presentation and T lymphocyte recognition. J Immunol 1991;147:2677-84.
44. 44. Takahashi H, Houghten R, Putney SD, et al. Structural requirements for class I MHC molecule mediated antigen presentation and cytotoxit T cell recognition of an immunodominant determinant of the human immunodeficiency virus envelope protein. J Exp Med 1989;170:2023-35.
45. 45. Hammond SA, Obah E, Stanhope P, et al. Characterisation of a conserved T cell epitope in HIV-1 gp41 recognised by vaccine-induced human cytolytic T cells. J Immunol 1991;146:1470-7.
46. 46. De Magistris MT, Alexander J, Coggeshall M, et al. Antigen analog major histocompatibility complexes act as antagonists of the T cell receptor. Cell 1992;68:625-34.
47. 47. Ostrov D, Krieger J, Sidney J, Sette A, Concannon P. T cell receptor antagonism by interaction between T cell receptor junctional residues and peptide antigen analogues. J Immunol 1993;150:4277-83.
48. 48. Klenerman P, Rowland-Jones S, McAdam S, et al. Cytotoxic T-cell activity antagonised by naturally occurring HIV-1 Gag variants. Nature 1994; 369:403-7.
49. 49. Bertolelti A, Sette A, Chisari FV, et al. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 1994;369:407-10.
50. 50. Sloan-Lancaster J, Evavold BD, Allen PM. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature 1993;363:156-9.
51. + T cells by primary HIV-1 infection. J Immunol 1997;158:807-15.
52. 4+ T cell responses associated with control of viremia. Science 1997; 278:1447-50; comment in Science 1997;278:1399-400; comment in Science 1998;279:1436.
53. 4+ T cell responses associated with control of viremia. Science 1997; 278:1447-50; comment in Science 1997;278:1399-400; comment in Science 1998;279:1436.
54. 4+ T cell responses associated with control of viremia. Science 1997; 278:1447-50; comment in Science 1997;278:1399-400; comment in Science 1998;279:1436.